XSS in Innokasmedical Vital Signs Monitor Vc150

CVE-2020-27262

Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 A stored cross-site scripting (XSS) vulnerability exists in the affected products that allow an attacker to inject arbitrary web script or HTML via the filename parameter to multiple update endpoints of the administrative web interface.

Vulnerability class: XSS (Cross-Site Scripting)

Published · last modified .

CVSS v3 metric

CVSS v3 base score 5.4 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N.

EPSS exploit prediction

EPSS: 0.007 (50.4th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 50th percentile — 50.4% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2020-27262: held from 0.007 to 0.007.

EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2020-27262?
CVE-2020-27262 is a medium-severity vulnerability in Innokasmedical Vital Signs Monitor Vc150, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2021-01-08.
How severe is CVE-2020-27262?
Medium severity. CVSS v3 base score is 5.4 out of 10.